Gemini Therapeutics IncCompany Details

Get alertedif Gemini Therapeutics Inc gets funded!
Company description

Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.


Funding history

DateDeal sizeInvestors 
October 17th, 2017$42,500,000Atlas Venture, Lightstone Ventures Lp, OrbiMed AdvisorsView Deal
May 2nd, 2016$2,000,001-View Deal
Create alert
Want to know when Gemini Therapeutics Inc gets funded?
Key people
Jean GeorgeDirector
Carl GordonDirector
James MclaughlinDirector, Executive Officer
Jason RhodesDirector
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!